200 likes | 210 Views
The PIPRA model: Collaborative management of public sector IP INNOVA workshop Stockholm, Sweden. Gregory D. Graff, PhD PIPRA. Overview. IP in agricultural R&D The problem: technology access for non-market applications The solution: PIPRA Four areas of activity
E N D
The PIPRA model:Collaborative management of public sector IPINNOVA workshopStockholm, Sweden Gregory D. Graff, PhD PIPRA INNOVA workshop
Overview • IP in agricultural R&D • The problem: technology access for non-market applications • The solution: PIPRA • Four areas of activity • Structure of the organization • Translating the model into R&D for neglected diseases? • Key issues and conclusions INNOVA workshop
The problem:Access to IP for small and non-market crops • Little application of new biotechnologies to improve genetics in ‘neglected’ crops • small market specialty crops • non-market ‘humanitarian’ applications in subsistence crops • Constraints on access to IP for development of “average” small market/non-market products • patent proliferation • fragmentation, a typical project requires IP controlled by multiple owners • lack of awareness, capacity • uncertainty • transaction costs • high licensing costs • refusals to deal • Constraints on out-licensing IP for academic/public sector • Excessive use of “exclusivity” tied up key enabling technologies • Very small field of potential commercial licensees with FTO • Fragmentation: no single institution can provide a development partner with full set of IP to ensure FTO • Large proportion of patents unlicensed INNOVA workshop
A solution: Coordinating public sector “technology providers” • Public research universities and institutes • Generate 25 percent of the IP in the agbio technology space • Share common goals to advance agriculture and benefit the public • PIPRA, the Public Intellectual Property Resource for Agriculture • Self initiated, growing ‘organically’, internally supported by administrations, researchers, and tech transfer • A commitment to manage IP to facilitate broadest possible application • Coordinated by a small professional staff engaged in ‘scaleable’ activities Source: Graff et al, Nature Biotechnology, 2003 INNOVA workshop
PIPRA activities: 4 platforms Each platform builds upon the previous ones: • IP data and analysis • Education, outreach, and advising on IP management and strategy • Development and dissemination of “unencumbered” research tools • Collaborative marketing and pooling of member institutions’ IP INNOVA workshop
IP data and analysis:Looking before we leap • PIPRA database • Integrated view of all member institutions’ agricultural IP, country by country • Includes licensing status, fields of use (i.e. availability) • Contact information of responsible manager at member OTT • What technologies can be accessed from public sector/PIPRA institutions? • FTO analyses • Background research by PIPRA staff • When needed, opinions obtained pro bono from leading IP attorneys of the PIPRA affiliates network • What is essential for FTO with a particular technology component? • Field of technology landscapes (horizontal view, across published technologies) • Integrating research literature and patent literature • Who has published/claimed what across a broad area? • R&D pipeline analyses (vertical view, down the development pipeline) • Integrating research and patent literature with product development data (fieldtrials, regulatory) • Who is moving what types of technologies toward market? INNOVA workshop
Education, outreach, & advisingBeing a guide through the patent thicket • Audiences: • PIPRA member OTT staff and researchers • Research sponsors • Potential licensees/users of IP • IP policy makers and institutional capacity builders in developing countries • Education: • Consultations • Workshops • Presentations • Website and newsletters • MIHR/PIPRA licensing handbook • PIPRA white papers • Peer reviewed publications • IP course curriculum development INNOVA workshop
Development of research tools:Responding to common IP needs with tangible solutions • Plant transformation vectors project (2006-2009) • Designs based on accessibility of IP • Pre-negotiated to assure • research use • humanitarian use • reasonable terms for conversion to commercial license • Maximize use of technology components owned by PIPRA members • Remainder of components from industry on defined terms • Sufficiently broad technical characterization to enable wide range of crop R&D • To be demonstrated in pilot projects • To be broadly disseminated under unified, standardized MTA • Potential for other kinds of research tools INNOVA workshop
Collaborative licensing:Creating an IP clearinghouse to facilitate licensing • Marketing • Leveraging the PIPRA database, IP analyses, and technology/industry expertise of PIPRA staff • Outreach materials highlight accessible technologies • Fielding inquiries from industry and “matchmaking” • Inclusion of technology components in developing PIPRA research tools • Potential for much more proactive marketing • Patent Pooling • Where complementarity requires coordination • Initially, coordinating IP around PIPRA research tools • Potential for extension into other areas INNOVA workshop
How PIPRA helps small market technology development in agriculture Public sector agbio IP ‘portfolio’ Product Development Partnerships INNOVA workshop
PIPRA structure • Consortium of member institutions • Currently 32 • Join by signing the PIPRA Memorandum of Understanding • Currently no fees • Governance • Executive Committee, drawn from member institutions • Campus Advisory Board • Funding • Rockefeller Foundation • Funded projects • Facilities • Provided as ‘in-kind’ support by UC Davis • Staff • Executive Director • Principals (PhD/JD level) • Analysts, Interns, Support Staff • Affiliates network • IT/patent data firms • Law firms and law schools • Others INNOVA workshop
PIPRA members (as of Jan 2006) • Arizona State University, as represented by Arizona Technology Enterprises LLC • Boyce Thompson Institute • Cornell University • Donald Danforth Plant Science Center • Fundación Chile, Chile • Iowa State University • International Maize and Wheat Improvement Center (CIMMYT), Mexico • International Potato Center (CIP), Peru • International Rice Research Institute (IRRI), Philippines • Kansas State University • Michigan State University • North Carolina State University • Ohio State University • Parco Technologico Padano, Italy • Purdue University • Salk Institute • St. Augustine University of Tanzania • Samuel Roberts Noble Foundation • State University of New Jersey, Rutgers • University of Arizona • University of Arkansas, Division of Agriculture • University of California-Berkeley • University of California-Davis • University of Florida • University of Georgia Research Foundation • University of Idaho • University of Kentucky • University of Missouri-Columbia • University of Saskatchewan, Canada • University of Wisconsin, Wisconsin Alumni Research Foundation • Virginia Tech, College of Agriculture and Life Sciences • Washington State University INNOVA workshop
PIPRA member institutions INNOVA workshop
PIPRA’s Network of Affiliates • Townsend and Townsend and Crew • Morrison and Foerster • DLA Piper Rudnick Gray Cary • Harness, Dickey, and Pierce • Foley Hoag • Edwards and Angell • Baker and McKenzie • Public Interest IP Advisors (PIIPA) • Washington University School of Law • Franklin Pierce Law School • CIP, Chalmers and Gothenberg Universities • M-CAM.com • Reel2.com • LightYears IP • Center for Application of Molecular Biology in International Agriculture (CAMBIA), Australia • African Agricultural Technology Foundation (AATF) • Instituto de Direito do Comercio International e Desenvolvimento (IDCID), Brazil INNOVA workshop
Possibilities for applying this model to R&D for neglected diseases? • Wider scope of technologies for human health: • Vaccines • Drugs/biologics • Diagnostics • Devices • Control over “background” and “foreground” IP plays an important role in PDPs for neglected diseases (Moran et al, 2005) • Variable capacity for IP management among PDPs • Some quite sophistocated • Others not so • Academic research already an important source of IP for PDPs (Moran et al, 2005) • 1/3 of neglected drug PDP spending goes to academics • 1/3 of PDP projects involve translating academic leads into neglected disease drugs ‘PDP’ still a new model, not yet applied to many potential technology developments. INNOVA workshop
Possibilities for applying this model to a regional system of universities? • Scalable services to assist local/on campus offices • data management • professional services • market analysis • IP marketing • Active or preferential ‘matchmaking’ with regional entrepreneurs and regional public-private technology development consortia • Collaborative representation of regional technology out-licensors on the global technology market • Define and set best practices in out licensing • Representation at international events • Establish satellite offices: London, Beijing, San Francisco INNOVA workshop
Supporting Materials INNOVA workshop
PIPRA’s 2005-2006 Executive Committee • Gerard BarryGolden Rice Network CoordinatorInternational Rice Research Institute (IRRI)E-mail: g.barry@cgiar.org • John ByattAssociate Director, Life Sciences University of FloridaE-mail: jbyatt@rgp.ufl.edu • Carlos FernandezFundación ChileE-mail: cfernandez@fundacionchile.cl • Lisa Lorenzen Director of Industry Relations & Biotechnology Liaison Iowa State University Email: llorenze@iastate.edu • Henry Lowendorf Associate Director Office of Cooperative Research Yale University Email: henry.lowendorf@yale.edu • Irvin MettlerSenior Licensing OfficerOffice of Technology LicensingUniversity of California-BerkeleyE-mail: imettler@berkeley.edu • Karel SchubertVice President, Technology Management & Science AdministrationDonald Danforth Plant Science CenterE-mail: kschubert@danforthcenter.org INNOVA workshop
PIPRA Staff and Contact Information PIPRA Plant Reproductive Biology Building Extension Center Drive University of CaliforniaPlant Sciences, Mail Stop 5 Davis, CA 95616-8780 Tel: +1 (530) 754-6717 Fax: +1 (530) 752-2278 www.pipra.org Alan Bennett, Executive DirectorEmail: abbennett@ucdavis.edu Phone: +1 (530) 754-1411 Sara Boettiger, Program ManagerEmail: sara.hearn@ucop.edu Phone: +1 (530) 754-6725 Cecilia Chi-Ham, Research ScientistEmail: clchiham@ucdavis.eduPhone: +1 (530) 754-6717 Josef Geoola, IP analyst Email: jngeoola@ucdavis.edu Phone: +1 (530) 754-6717 Gregory Graff, Research Economist Email: gdgraff@ucdavis.edu Phone: +1 (530) 752-2705 INNOVA workshop
References • Gregory D. Graff, Susan E. Cullen, Kent J Bradford, David Zilberman, and Alan B. Bennett, “The Public-Private Structure of Intellectual Property Ownership in Agricultural Biotechnology,” Nature Biotechnology, 21(9), September 2003, 989-995 • Amy Kapczynski, Samantha Chaifetz, Zachary Katz, and Jochai Benkler, “Addressing Global Health Inequities: An Open Licensing Approach for University Innovations,” Berkeley Technology Law Journal, 20(2), Spring 2005, 1032-1114 • Mary Moran, Anne-Laure Ropars, Javier Guzman, Jose Diaz, and Christopher Garrison, The New Landscape of Neglected Disease Drug Development, Pharmaceutical R&D Policy Project, London School of Economics, The Wellcome Trust: London, September 2005 • Lori Pressman, Richard Burgess, Robert M Cook-Deegan, Stephen J McCormack, Io Nami-Wolk, Melissa Soucy, and LeRoy Walters, “The Licensing of DNA Patents by US Academic Institutions: an Empirical Study,” Nature Biotechnology, 24(1), January 2006, 31-39 INNOVA workshop